Cite
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia.
MLA
Basile, Umberto, et al. “Biomarkers of Minimal Residual Disease in Rituximab-Treated Patients with Mixed Cryoglobulinemia.” Biotechnology & Applied Biochemistry, vol. 68, no. 2, Apr. 2021, pp. 319–29. EBSCOhost, https://doi.org/10.1002/bab.1929.
APA
Basile, U., Gulli, F., Napodano, C., Pocino, K., Basile, V., Marrapodi, R., Colantuono, S., Todi, L., Marino, M., Rapaccini, G. L., & Visentini, M. (2021). Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia. Biotechnology & Applied Biochemistry, 68(2), 319–329. https://doi.org/10.1002/bab.1929
Chicago
Basile, Umberto, Francesca Gulli, Cecilia Napodano, Krizia Pocino, Valerio Basile, Ramona Marrapodi, Stefania Colantuono, et al. 2021. “Biomarkers of Minimal Residual Disease in Rituximab-Treated Patients with Mixed Cryoglobulinemia.” Biotechnology & Applied Biochemistry 68 (2): 319–29. doi:10.1002/bab.1929.